Marine Biomedical Achieves FDA Clearance
Filed with ASX ·
6ix is reading this filing.
Earlier from Orthocell
- Strongest U.S. Remplir Sales Month Since Launch
- Q1 FY27 OCC Investor Presentation
- Quarterly Activity Report & Appendix 4C
- Remplir Shows Excellent Early Prostatectomy Results
- Orthocell Achieves First Remplir Sales in Thailand
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell